Veracyte Inc [VCYT] stock prices are up 1.95% to $34.98 at the moment. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The VCYT shares have gain 2.52% over the last week, with a monthly amount glided 6.52%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Veracyte Inc [NASDAQ: VCYT] stock has seen the most recent analyst activity on October 16, 2024, when UBS initiated its Buy rating and assigned the stock a price target of $43. Previously, Guggenheim started tracking the stock with Buy rating on October 10, 2024, and set its price target to $40. On February 23, 2024, Needham reiterated its Buy rating and revised its price target to $33 on the stock. Raymond James downgraded its rating to a Mkt Perform. Scotiabank initiated its recommendation with a Sector Outperform and recommended $33 as its price target on January 05, 2023. Stephens started tracking with a Overweight rating for this stock on January 07, 2022, and assigned it a price target of $52.
The stock price of Veracyte Inc [VCYT] has been fluctuating between $18.61 and $35.51 over the past year. Currently, Wall Street analysts expect the stock to reach $26 within the next 12 months. Veracyte Inc [NASDAQ: VCYT] shares were valued at $34.98 at the most recent close of the market. An investor can expect a potential drop of -25.67% based on the average VCYT price forecast.
Analyzing the VCYT fundamentals
The Veracyte Inc [NASDAQ:VCYT] reported sales of 399.58M for trailing twelve months, representing a surge of 26.69%. Gross Profit Margin for this corporation currently stands at 0.66% with Operating Profit Margin at -0.08%, Pretax Profit Margin comes in at -0.14%, and Net Profit Margin reading is -0.14%. To continue investigating profitability, this company’s Return on Assets is posted at -0.04, Equity is -0.05 and Total Capital is -0.03. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.02.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 34.02 points at the first support level, and at 33.05 for the second support level. However, for the 1st resistance point, the stock is sitting at 35.49, and for the 2nd resistance point, it is at 35.99.
Ratios To Look Out For
It’s worth pointing out that Veracyte Inc [NASDAQ:VCYT]’s Current Ratio is 4.44. As well, the Quick Ratio is 4.17, while the Cash Ratio is 3.26. Considering the valuation of this stock, the price to sales ratio is 6.84, the price to book ratio is 2.37.
Transactions by insiders
Recent insider trading involved JONES EVAN/ FA, Director, that happened on Sep 19 ’24 when 5173.0 shares were sold. Chief Commercial Officer-CLIA, Leite John completed a deal on Sep 04 ’24 to sell 5479.0 shares. Meanwhile, Officer JOHN LEITE bought 5479.0 shares on Sep 04 ’24.
